Professor Peter Timms, from QUT's Institute of Health and Biomedical Innovation, said chlamydia was a major threat to the continued survival of koalas with almost all populations affected by the disease.
"The trial is planned to begin before the end of the year and will test the vaccine's ability to induce a good immune response in the koala against chlamydia," he said.
"Assuming that this first trial is successful, then future trials can determine if this immune response is able to protect the koalas against chlamydial disease.
"We've been able to develop the vaccine for koalas as a result of our studies on the development of human chlamydial vaccines done in the mouse model. We have identified several novel vaccine proteins that we hope will protect koalas as well."
Professor Timms said chlamydia in koalas was a significant cause of infertility, urinary tract infections, and inflammation in the lining of the eye that often led to blindness.
"The numbers of koalas with chlamydia seems to be increasing," he said.
"As much as 40-50 per cent of koalas coming into care in both Queensland and NSW are showing clinical signs of the disease and it seems to be getting worse."
The vaccine will be administered to a small number of koalas via an injection either under the skin or intramuscularly.
"The first phase of the trial will run for between six and 12 months," he said.
"We will have initial results within the first six months but we will continue to monitor the koalas for 12 months to determine how long the vaccine stimulates an immune response in the koalas and whether or not a booster shot is required.
"There is no danger that a koala without chlamydia will contract the disease from the vaccine."
Professor Timms said the vaccine trial was a significant step in the right direction in fighting the threat of chlamydia in koalas.
QUT's koala vaccine team also includes Professor Ken Beagely and PhD student Asad Sukar.
"While we have funding for the initial trial we are hoping to attract additional financial support for us to be able to continue this important work," he said.
"We seem to be doing good science but we need more funding. We are looking for corporate or individual support to fund further research in this area."
Professor Timms said by investing in chlamydia research, people were giving hope to the future survival of koalas.
QUT's extensive research into chlamydia will be presented at the 2007 International Chlamydia Conference which is on today and tomorrow (July 16-17) at Kelvin Grove.
The conference, hosted by QUT, will bring together national and international experts to discuss the latest research and developments.
Sandra Hutchinson | EurekAlert!
Invasive Insects Cost the World Billions Per Year
04.10.2016 | University of Adelaide
Malaysia's unique freshwater mussels in danger
27.09.2016 | The University of Nottingham Malaysia Campus
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy